Crane Deborah D, Ireland Robin, Alinger Joshua B, Small Pamela, Bosio Catharine M
Immunity to Pulmonary Pathogens Section, Laboratory of Intracellular Parasites, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, USA.
Clin Vaccine Immunol. 2013 Oct;20(10):1531-40. doi: 10.1128/CVI.00319-13. Epub 2013 Aug 7.
Francisella tularensis is a Gram-negative facultative intracellular pathogen that causes an acute lethal respiratory disease in humans. The heightened virulence of the pathogen is linked to its unique ability to inhibit Toll-like receptor (TLR)-mediated inflammatory responses. The bacterial component and mechanism of this inhibition are unknown. Here we show that lipids isolated from virulent but not attenuated strains of F. tularensis are not detected by host cells, inhibit production of proinflammatory cytokines by primary macrophages in response to known TLR ligands, and suppress neutrophil recruitment in vivo. We further show that lipid-mediated inhibition of inflammation is dependent on TLR2, MyD88, and the nuclear hormone and fatty acid receptor peroxisome proliferator-activated receptor α (PPARα). Pathogen lipid-mediated interference with inflammatory responses through the engagement of TLR2 and PPARα represents a novel manipulation of host signaling pathways consistent with the ability of highly virulent F. tularensis to efficiently evade host immune responses.
土拉弗朗西斯菌是一种革兰氏阴性兼性胞内病原体,可导致人类急性致死性呼吸道疾病。该病原体的高毒力与其独特的抑制Toll样受体(TLR)介导的炎症反应的能力有关。这种抑制作用的细菌成分和机制尚不清楚。在此,我们表明,从土拉弗朗西斯菌的强毒株而非减毒株中分离出的脂质未被宿主细胞检测到,可抑制原代巨噬细胞对已知TLR配体的反应中促炎细胞因子的产生,并在体内抑制中性粒细胞募集。我们进一步表明,脂质介导的炎症抑制依赖于TLR2、MyD88以及核激素和脂肪酸受体过氧化物酶体增殖物激活受体α(PPARα)。病原体脂质通过TLR2和PPARα的结合对炎症反应进行的干扰,代表了宿主信号通路的一种新的调控方式,这与高毒力土拉弗朗西斯菌有效逃避宿主免疫反应的能力相一致。